Evidence map›Paper›PMID 34533981›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Reply to S. Sommerlatte et al.

Clark DuMontier, Kah Poh Loh, Enrique Soto-Perez-de-Celis, William Dale

Abstract readLetterComment
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Clark DuMontierClark DuMontier, MD, MPH, New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, MA, Brigham and Women's Hospital, Boston, MA; Kah Poh Loh, MBBCh, BAO, MS, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY; Enrique Soto-Perez-de-Celis, MD, Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; and William Dale, MD, PhD, City of Hope Comprehensive Cancer Center, Duarte, CA.ORCID 0000-0003-2582-7816
Kah Poh LohClark DuMontier, MD, MPH, New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, MA, Brigham and Women's Hospital, Boston, MA; Kah Poh Loh, MBBCh, BAO, MS, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY; Enrique Soto-Perez-de-Celis, MD, Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; and William Dale, MD, PhD, City of Hope Comprehensive Cancer Center, Duarte, CA.ORCID 0000-0002-6978-0418
Enrique Soto-Perez-de-CelisClark DuMontier, MD, MPH, New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, MA, Brigham and Women's Hospital, Boston, MA; Kah Poh Loh, MBBCh, BAO, MS, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY; Enrique Soto-Perez-de-Celis, MD, Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; and William Dale, MD, PhD, City of Hope Comprehensive Cancer Center, Duarte, CA.ORCID 0000-0002-7301-2163
William DaleClark DuMontier, MD, MPH, New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, MA, Brigham and Women's Hospital, Boston, MA; Kah Poh Loh, MBBCh, BAO, MS, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY; Enrique Soto-Perez-de-Celis, MD, Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; and William Dale, MD, PhD, City of Hope Comprehensive Cancer Center, Duarte, CA.ORCID 0000-0001-8674-9394

Funding

Translational Researchin Aging Trainnig ProgramT32AG023480 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI LIPSITZ, LEWIS · 2004 to 2024
$7.6M
Geriatric Oncology Research Infrastructure to Improve Clinical CareR33AG059206 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WILLIAM DALE, Heidi Diana Klepin · 2020 to 2026
$5.1M
Mentoring the Next Generation of Geriatric Oncology Researchers in Patient-Oriented Research to Improve the Care of Older Adults with CancerK24AG055693 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WILLIAM DALE · 2018 to 2026
$1.4M
A Novel Mobile Health Exercise Intervention for Older Patients with Myeloid NeoplasmsK99CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2019 to 2020
$385k
Integration of Geriatric Measures Alongside Disease-Based Measures to Advance Precision Oncology for Older Veterans with Multiple MyelomaIK2CX002218 · VA · VA BOSTON HEALTH CARE SYSTEM · PI DUMONTIER, CLARK WILLIAM · 2021 to 2024
–
CSRD VA IK2 CX002218NCI NIH HHS K99 CA237744NIA NIH HHS K24 AG055693NIA NIH HHS R33 AG059206NIA NIH HHS T32 AG023480
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34533981
PMCPMC8601260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.